International Stem Cell Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Semechkin Andrey, was filed 22 Jan 2019.
International Stem Cell Corp: what insiders have been doing
International Stem Cell Corp, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). 2 insiders have disclosed 2 filings since 24 October 2025.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €9,034. The largest single trade was a sale of €9,034 by Maier Paul V, published on 15 September 2026, equal to 0.45% of the market capitalisation.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Across the 282 companies tracked on its exchange, the median is 8 filings; at 2 filings, this issuer sits below that mark. The full history, which starts in 2007, counts 62 purchases against 81 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 9.1 m USD and net income at -418,000 USD.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -32.7%Entry US$1.56 · Close at T+365 US$1.05
- -46.0%Entry US$7.50 · Close at T+365 US$4.05
- -67.1%Entry US$12.00 · Close at T+365 US$3.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 32,802 shares@ US$0.320.45% mcap43.6% of flowCommon StockSEC:0001683168-26-007164:0
- 32,802 shares@ US$0.360.51% mcap49.1% of flowCommonSEC144:0001949846-26-000580
- 1,350 shares@ US$1.257.3% of flowCommon StockSEC:0001683168-19-001143:0
- 599,222 shares@ US$1.7595.8% of flowCommon StockSEC:0001683168-19-000172:0Canonical exit: 21 Apr 2019 (T+90)
- 1,800 shares@ US$1.094.7% of flowCommon StockSEC:0001683168-18-003618:0
- 1,800 shares@ US$1.677.3% of flowCommon StockSEC:0001683168-18-003618:1
- 2,778 shares@ US$1.093.6% of flowCommon StockSEC:0001683168-18-003617:0
- 10,636 shares@ US$1.5419.7% of flowCommon StockSEC:0001683168-18-003617:2
- 7,858 shares@ US$1.1010.4% of flowCommon StockSEC:0001683168-18-003617:1
- 1,494 shares@ US$1.101.9% of flowCommon StockSEC:0001683168-18-002939:0
- 1,494 shares@ US$1.582.8% of flowCommon StockSEC:0001683168-18-002939:1
- 4,900 shares@ US$1.106.3% of flowCommon StockSEC:0001683168-18-002467:0
- 4,900 shares@ US$1.589.1% of flowCommon StockSEC:0001683168-18-002467:1
- 3,556 shares@ US$1.094.6% of flowCommon StockSEC:0001683168-18-002459:0
- 5,748 shares@ US$1.107.5% of flowCommon StockSEC:0001683168-18-002459:1
- 9,304 shares@ US$1.5817.4% of flowCommon StockSEC:0001683168-18-002459:2
- 1,100 shares@ US$1.091.4% of flowCommon StockSEC:0001683168-18-001975:0
- 1,100 shares@ US$1.582.0% of flowCommon StockSEC:0001683168-18-001975:1
- 2,833 shares@ US$1.093.6% of flowCommon StockSEC:0001683168-18-001945:0
- 2,833 shares@ US$1.585.2% of flowCommon StockSEC:0001683168-18-001945:1
- 200 shares@ US$1.090.3% of flowCommon StockSEC:0001683168-18-001809:0
- 200 shares@ US$1.590.4% of flowCommon StockSEC:0001683168-18-001809:1
- 1,200 shares@ US$1.091.5% of flowCommon StockSEC:0001683168-18-001801:0
- 1,200 shares@ US$1.602.2% of flowCommon StockSEC:0001683168-18-001801:1
- 4,328 shares0Common StockSEC:0001683168-18-001777:0
25 of 253 declarations
About International Stem Cell Corp
International Stem Cell Corp is a biotechnology company focused on developing therapies based on stem cells. It is listed on NASDAQ under the symbol ISCO.
